Cortisol activates four simultaneous damage mechanisms — M1 through M4. Any supplement claiming to protect the stomach during stress should be evaluated against all four. Antacids address M2.
M1 — COX inhibition and prostaglandin depletion
Cortisol suppresses cyclooxygenase (COX-1 and COX-2) enzymes in gastric epithelial cells. COX enzymes produce prostaglandins E2 and I2 — signalling molecules that maintain three critical gastric defences:
Mucus secretion from surface epithelial cells (the physical barrier between acid and the lining). Bicarbonate secretion (the chemical buffer neutralising acid at the mucosal surface). Mucosal blood flow (delivering oxygen and nutrients that sustain barrier cell function). When COX is suppressed, all three decline simultaneously. The mucosal surface is physically and chemically less protected against the acid it continues to produce.
M2 — Parietal cell stimulation and acid increase
Cortisol and the associated autonomic nervous system activation (sympathetic activation, reduced vagal parasympathetic tone) directly stimulate parietal cells in the gastric fundus. Parietal cells produce hydrochloric acid (HCl) — and under cortisol stimulation, they produce more of it. The stomach is simultaneously less protected (M1) and more acidic (M2). This compound mechanism is why stress-related gastric pain is often significantly more intense than stress alone should produce — two mechanisms are acting simultaneously.
M3 — ROS accumulation and membrane damage
The prostaglandins suppressed by cortisol's COX inhibition (M1) are not just barrier-maintenance molecules. They also upregulate the expression of superoxide dismutase (SOD) and catalase — the primary antioxidant enzymes in gastric epithelial cells. When prostaglandins drop, these antioxidant defences are not maintained. Reactive oxygen species (ROS) — superoxide anion, hydrogen peroxide, hydroxyl radical — accumulate in gastric epithelial cells. ROS directly damages cell membranes through lipid peroxidation, compromises mitochondrial function, and contributes to epithelial cell death — producing the erosions observed in more severe stress-related mucosal damage.
M4 — NF-kB activation and EGFR/ERK suppression
Mechanism 4 is the inflammatory endpoint that produces sustained mucosal damage beyond the immediate stress episode. Cortisol activates NF-kB through two pathways: the non-canonical glucocorticoid receptor (GR)-NF-kB signalling pathway (direct); and ROS-mediated NF-kB activation from M3 (indirect). Active NF-kB drives IL-6, IL-8, and TNF-α production — the same cytokine cascade H. pylori activates. Crucially, sustained NF-kB activity suppresses the EGFR/ERK signalling pathway responsible for mucosal cell regeneration — creating a state where the mucosa is being damaged and simultaneously prevented from fully repairing itself.
How the four mechanisms compound each other
M1 (prostaglandin loss) allows acid to contact the epithelium directly → M2 (elevated acid) now contacts a thinner barrier → M3 (ROS) accumulates because the prostaglandin-dependent antioxidant support is gone → M4 (NF-kB) is activated by both the GR pathway and the ROS from M3 → NF-kB suppresses EGFR/ERK repair → the damaged mucosa cannot repair itself as fast as it is being damaged. Each mechanism worsens the context for the next.
Why antacids address only M2
| Mechanism | What causes it | Does antacid help? | Does TumGard help? |
|---|---|---|---|
| M1 — Prostaglandin depletion | COX suppression by cortisol | ✗ No | ~ Indirect (NF-kB controls some COX expression) |
| M2 — Elevated acid | Parietal cell stimulation | ✓ Yes — neutralises acid | ✗ Not acid suppression |
| M3 — ROS accumulation | Antioxidant defence collapse | ✗ No | ✓ Quercetin antioxidant activity |
| M4 — NF-kB + EGFR/ERK deficit | GR signalling + ROS | ✗ No | ✓ Quercetin (NF-kB) + Glabridin (EGFR/ERK) |
References
- Ye YN et al. Licorice flavonoids and gastric mucosal repair via EGFR/ERK pathway. Journal of Ethnopharmacology. 2023;302:115866. PMID 36842733. Glabridin's EGFR/ERK activation — the mechanism that addresses M4's repair suppression.
- Xiao ZP et al. Quercetin as inhibitor of H. pylori urease and NF-kB pathway. European Journal of Medicinal Chemistry. 2006;41(4):476–82. PMID 16887239. Quercetin's NF-kB inhibition via IκB stabilisation — the mechanism that addresses M4's inflammatory cascade from cortisol GR and ROS activation.
- Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380:1158–1165. PMID 30699316. NF-kB and EGFR/ERK mechanism — the convergent endpoint that cortisol and H. pylori share, and the mechanism basis for TumGard's dual relevance.